-- Health care stocks were mixed pre-bell Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) 0.2% lower and the iShares Biotechnology ETF (IBB) up 0.4%
Spyre Therapeutics (SYRE) shares were up more than 27% after the company said its SPY001 investigational treatment for moderate-to-severely active ulcerative colitis met its primary and key secondary endpoints in a phase 2 trial.
JNBY Design (HKG:3306) said it awarded a 600 million yuan construction contract to Zhejiang Construction Engineering Group, according to a Hong Kong bourse filing Friday.Shares of the apparel company gained nearly 3% in late morning trade Monday.Under the contract, Zhejiang Construction will be responsible for building JNBY Design's production base on a portion of land in China's Hangzhou.Construction is due for completion by Dec. 31, 2028, the firm said.
China Chengtong Development (HKG:0217) said its Chengtong Financial Leasing unit entered into a sale and leaseback arrangement with a unit of China Huadian, according to an April 17 Hong Kong bourse filing.Shares of the property developer were up over 1% in morning trade on Monday.Under the arrangement, Chengtong Financial Leasing will purchase wind power equipment and related assets for 220 million yuan and lease them back for two years for about 227.6 million yuan.The transaction is expected to generate lease interest income of about 7.6 million yuan for the unit.
Jio Financial Services' (NSE:JIOFIN, BOM:543940) consolidated profit declined to 2.72 billion Indian rupees in the fiscal fourth quarter ended March 31, from 3.16 billion rupees a year ago.Earnings per share contracted to 0.43 rupees from 0.50 rupees a year earlier, the financial services company said in a Friday filing to the Indian stock exchanges.Revenue from operations in fiscal Q4 also increased to 10.2 billion rupees from 4.93 billion rupees a year ago.The company's board also recommended a dividend of 0.60 rupees per equity share of 10 rupees each for the financial year ended March 31.